Dilated cardiomyopathy in children

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue SUPPL. 452, 2006, Pages 14-16

  Giulia Gagliardi, Maria ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Children; Idiopathic dilated cardiomyopathy; Immunosuppression; Myocarditis

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

AUTOIMMUNITY; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONVALESCENCE; DISEASE MARKER; EPIDEMIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RELIABILITY; UNSPECIFIED SIDE EFFECT;

AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS; PROGNOSIS;

EID: 33745726725     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035320600649358     Document Type: Conference Paper

References (11)

1. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348: 1647-55.
2. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1: 3-14.
3. Kuhl U, Noutsias M, Seeberg B, Schultheiss HP. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 1996;75:295-300.
4. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up result. Circulation 2001;104:39-45.
5. Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, et al. Novel organ-specific circulating autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15: 1527-34.
6. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
7. Gagliardi MG, Bevilacqua M, Squitieri C, Boldrini R, Di Julio DP, Marcelletti C. Dilated cardiomyopathy caused by acute myocarditis in pediatric patients: evolution of myocardial damage in a group of potential heart transplant candidates. J Heart Lung Transplant 1993;12 Suppl:S224-9.
8. Kleinert S, Weintraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997;16:1248-54.
9. Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM, et al. Clinical outcome of acute myocarditis in childhood. Heart 1999;82:226-33.
10. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Globulin treatment of acute myocarditis in the pediatric population. Circulation 1994;89:252-7.
11. Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Diomedi Camassei F, et al. Long-term follow-up of children with myocarditis treated by immunosuppression and children with dilated cardiomyopathy. Heart 2004; in press.